La CNN recoge testimonios que aseguran que despus de un ao de abandonar el uso de estos frmacos, an persisten las molestias
Holding onto muscle can support a steadier health journey
The recommended subcutaneous injection sites are the abdomen (avoiding 5 cm around the navel), the outer upper thigh, and the outer upper arm
To view or add a comment, sign in Latest News : "Sultiame Reduces Apnoea Events in Phase 2 FLOW Trial" The phase 2 FLOW trial shows sultiame caused consistent, dose-dependent improvements in obstructive sleep apnoea, nocturnal hypoxia, and sleep quality, highlighting its potential as a pharmacological treatment
The company reported promising results from its studies, indicating potential for regulatory pathways to establish oral versions of these drugs

Semaglutide: Double-edged sword with risks and benefits, National Library of Medicine (2025) GLP-1 agonists can affect mood: A case of worsened depression on Ozempic (semaglutide), Innovations in Clinical NeuroScience (2024) The risk of depression, anxiety, and suicidal behavior in patients with obesity on glucagon like peptide-1 receptor agonist therapy, Nature (2024) New study finds Ozempic and Mounjaro protect the heart too, Science Daily (2025) The FLOW study: Effects of Semaglutide on chronic kidney disease in patients with Type 2 diabetes, International Society of Nephrology (2024) Update on semaglutide risks, American Academy of Ophthalmology (2021) Can Ozempic affect eye health?, American Academy of Ophthalmology (2024) Common side effects, Ozempic Wiljon Beltre, board-certified and fellowship-trained surgeon specializing in bariatric and metabolic surgery Jennifer Brown, MD, dual board-certified physician in family medicine and obesity medicine Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
